What are the major opportunities in the Short-Acting Insulin market? What are the strategies for the Short-Acting Insulin market?

For detailed insights on the major opportunities and strategies in the Short-Acting Insulin market, Read More

How does the Short-Acting Insulin market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Short-Acting Insulin market growth and SWOT analysis of the Short-Acting Insulin industry, Read More

For detailed insights on the mergers and acquisitions in the Short-Acting Insulin industry,

What are the key dynamics influencing the Short-Acting Insulin market growth? SWOT analysis of the Short-Acting Insulin market. Read More

Short-Acting Insulin Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Short-Acting Insulin Market Report 2026

Name: Short-Acting Insulin Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Formulation (Regular Insulin, Rapid-Acting Insulin), By Dosage Form (Vials, Pre-filled Pens, Cartridges), By Route Of Administration (Subcutaneous, Intravenous), By Patient Type (Type 1 Diabetes, Type 2 Diabetes), By Distribution Channel (Pharmacies, Hospital Pharmacies, Online Pharmacies) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Short-Acting Insulin Market Overview

• Short-Acting Insulin market size has reached to $11.54 billion in 2025

• Expected to grow to $14.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%

• Growth Driver: Surging Type 1 Diabetes Prevalence Highlights Need For Effective Insulin Therapy

• Market Trend: Advancing Interchangeable Rapid-Acting Insulin For Flexible Diabetes Management

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Short-Acting Insulin Market?

Short-acting insulin is a type of insulin that is used to control blood sugar levels during or after meals. It begins to work within 30 minutes to 1 hour, peaks at around 2-3 hours, and has a duration of action of 4-6 hours. Short-acting insulin plays a vital role in regulating blood glucose by facilitating the uptake of glucose into cells, which the body then uses for energy, particularly after the consumption of food.

The main formulation types of short-acting insulin are regular insulin and rapid-acting insulin. Regular insulin is a fast-acting form of insulin used to control blood sugar levels in people with diabetes, typically administered before meals. These formulations are available in different dosage forms, including vials, pre-filled pens, and cartridges, and are administered through subcutaneous or intravenous routes. It is prescribed for both type 1 and type 2 diabetes patients and distributed through various channels, such as retail pharmacies, hospital pharmacies, and online pharmacies.

Short-Acting Insulin Market Global Report 2026 Market Report bar graph

What Is The Short-Acting Insulin Market Size and Share 2026?

The short-acting insulin market size has grown strongly in recent years. It will grow from $11.54 billion in 2025 to $12.14 billion in 2026 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to high prevalence of diabetes, widespread insulin therapy adoption, hospital-based diabetes management, expansion of insulin access programs, improved diabetes diagnosis rates.

What Is The Short-Acting Insulin Market Growth Forecast?

The short-acting insulin market size is expected to see strong growth in the next few years. It will grow to $14.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to rising type 2 diabetes incidence, increasing insulin dependence, growth in home-based diabetes care, expansion of insulin delivery technologies, rising demand for fast-acting insulin. Major trends in the forecast period include rising demand for post-meal blood glucose control, increasing use of rapid-acting insulin analogues, growing adoption of pre-filled insulin pens, expansion of intensive insulin therapy regimens, increased focus on tight glycemic management.

Book your 30 minutes free consultation with our research experts

Global Short-Acting Insulin Market Segmentation

1) By Formulation: Regular Insulin, Rapid-Acting Insulin

2) By Dosage Form: Vials, Pre-filled Pens, Cartridges

3) By Route Of Administration: Subcutaneous, Intravenous

4) By Patient Type: Type 1 Diabetes, Type 2 Diabetes

5) By Distribution Channel: Pharmacies, Hospital Pharmacies, Online Pharmacies

Subsegments:

1) By Regular Insulin: Human Regular Insulin, Animal-Derived Regular Insulin, Other Regular Insulin

2) By Rapid-Acting Insulin: Insulin Lispro, Insulin Aspart, Insulin Glulisine

What Is The Driver Of The Short-Acting Insulin Market?

The increasing prevalence of type 1 diabetes is expected to fuel the growth of the short-acting insulin market going forward. Type 1 diabetes is an autoimmune condition where the body destroys insulin-producing cells, requiring lifelong insulin therapy. The rising prevalence of Type 1 diabetes is driven by genetic factors, environmental triggers, and increasing autoimmune disorders. Short-acting insulin helps manage type 1 diabetes by providing rapid blood sugar control and mimicking natural insulin response. For instance, in December 2023, according to Diabetes Australia, an Australia-based organization that works to raise awareness about diabetes, in 2022, approximately 134,000 Australians were living with Type 1 diabetes. This figure increased to 135,423 in 2023. Therefore, the increasing prevalence of type 1 diabetes is driving the growth of the short-acting insulin industry.

Key Players In The Global Short-Acting Insulin Market

Major companies operating in the short-acting insulin market are Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, Biocon Limited, Lupin Limited, Wockhardt Ltd., Julphar (Gulf Pharmaceutical Industries), Geropharm LLC, Bioton S.A., Gan & Lee Pharmaceuticals Co. Ltd., Lannett Company Inc., MannKind Corporation, ADOCIA S.A.S., Baxter International Inc., Tonghua Dongbao Pharmaceutical Co. Ltd., United Laboratories International Holdings Ltd., Bharat Biotech International Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd., Dongbao Enterprise Group Co. Ltd., Aspen Pharmacare Holdings Limited

Global Short-Acting Insulin Market Trends and Insights

Major companies operating in the short-acting insulin market are focusing on innovative products such as interchangeable rapid-acting insulin biologic to enhance glycemic control and provide flexible substitution options for patients with diabetes. Interchangeable rapid-acting insulin biologic refers to a biologically derived insulin formulation that acts quickly to lower blood glucose levels after meals and is approved by regulatory authorities to be substituted for another equivalent insulin product without requiring a new prescription, offering flexibility in diabetes management and maintaining consistent glycemic control. For instance, in July 2025, Biocon Biologics, a US-based biosimilars company headquartered in India and the U.S., secured FDA approval for Kirsty (insulin aspart xjhz) the first and only interchangeable rapid-acting insulin aspart in the United States. Kirsty is a biosimilar to NovoLog (insulin aspart), with clinical and analytical data demonstrating no meaningful differences in safety, efficacy, purity, and potency. It is available as a 100 units/mL formulation in both a single-patient-use prefilled pen (for subcutaneous use) and a multi-dose vial (for both subcutaneous and intravenous administration), aimed at improving glycemic control in adults and children with diabetes mellitus.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Short-Acting Insulin Market?

In December 2024, Lupin Limited, an India-based pharmaceutical company, acquired the Humulin range in India from Eli Lilly & Company for an undisclosed amount. With this acquisition, Lupin aims to strengthen its position in the insulin market in India by expanding its product portfolio with the addition of Huminsulin from Eli Lilly and Company. Eli Lilly and Company is a US-based pharmaceutical company specializing in insulin products such as short-acting insulin.

Regional Insights

North America was the largest region in the short-acting insulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Short-Acting Insulin Market?

The short-acting insulin market consists of sales of human insulin, analogue insulin, and biosimilars. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Short-Acting Insulin Market Report 2026?

The short-acting insulin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the short-acting insulin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Short-Acting Insulin Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$12.14 billion
Revenue Forecast In 2035	$14.87 billion
Growth Rate	CAGR of 5.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Formulation, Dosage Form, Route Of Administration, Patient Type, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, Biocon Limited, Lupin Limited, Wockhardt Ltd., Julphar (Gulf Pharmaceutical Industries), Geropharm LLC, Bioton S.A., Gan & Lee Pharmaceuticals Co. Ltd., Lannett Company Inc., MannKind Corporation, ADO
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Short-Acting Insulin Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Short-Acting Insulin Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Short-Acting Insulin Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Short-Acting Insulin Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Demand For Post-Meal Blood Glucose Control

4.2.2 Increasing Use Of Rapid-Acting Insulin Analogues

4.2.3 Growing Adoption Of Pre-Filled Insulin Pens

4.2.4 Expansion Of Intensive Insulin Therapy Regimens

4.2.5 Increased Focus On Tight Glycemic Management

5. Short-Acting Insulin Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diabetes Clinics

5.3 Retail Pharmacies

5.4 Homecare Patients

5.5 Specialty Pharmacies

6. Short-Acting Insulin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Short-Acting Insulin Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Short-Acting Insulin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Short-Acting Insulin Market Size, Comparisons And Growth Rate Analysis

7.3. Global Short-Acting Insulin Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Short-Acting Insulin Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Short-Acting Insulin Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Short-Acting Insulin Market Segmentation

9.1. Global Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Regular Insulin, Rapid-Acting Insulin

9.2. Global Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vials, Pre-filled Pens, Cartridges

9.3. Global Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Subcutaneous, Intravenous

9.4. Global Short-Acting Insulin Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Type 1 Diabetes, Type 2 Diabetes

9.5. Global Short-Acting Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmacies, Hospital Pharmacies, Online Pharmacies

9.6. Global Short-Acting Insulin Market, Sub-Segmentation Of Regular Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Human Regular Insulin, Animal-Derived Regular Insulin, Other Regular Insulin

9.7. Global Short-Acting Insulin Market, Sub-Segmentation Of Rapid-Acting Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Insulin Lispro, Insulin Aspart, Insulin Glulisine

10. Short-Acting Insulin Market Regional And Country Analysis

10.1. Global Short-Acting Insulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Short-Acting Insulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Short-Acting Insulin Market

11.1. Asia-Pacific Short-Acting Insulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Short-Acting Insulin Market

12.1. China Short-Acting Insulin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Short-Acting Insulin Market

13.1. India Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Short-Acting Insulin Market

14.1. Japan Short-Acting Insulin Market Overview

14.2. Japan Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Short-Acting Insulin Market

15.1. Australia Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Short-Acting Insulin Market

16.1. Indonesia Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Short-Acting Insulin Market

17.1. South Korea Short-Acting Insulin Market Overview

17.2. South Korea Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Short-Acting Insulin Market

18.1. Taiwan Short-Acting Insulin Market Overview

18.2. Taiwan Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Short-Acting Insulin Market

19.1. South East Asia Short-Acting Insulin Market Overview

19.2. South East Asia Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Short-Acting Insulin Market

20.1. Western Europe Short-Acting Insulin Market Overview

20.2. Western Europe Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Short-Acting Insulin Market

21.1. UK Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Short-Acting Insulin Market

22.1. Germany Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Short-Acting Insulin Market

23.1. France Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Short-Acting Insulin Market

24.1. Italy Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Short-Acting Insulin Market

25.1. Spain Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Short-Acting Insulin Market

26.1. Eastern Europe Short-Acting Insulin Market Overview

26.2. Eastern Europe Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Short-Acting Insulin Market

27.1. Russia Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Short-Acting Insulin Market

28.1. North America Short-Acting Insulin Market Overview

28.2. North America Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Short-Acting Insulin Market

29.1. USA Short-Acting Insulin Market Overview

29.2. USA Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Short-Acting Insulin Market

30.1. Canada Short-Acting Insulin Market Overview

30.2. Canada Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Short-Acting Insulin Market

31.1. South America Short-Acting Insulin Market Overview

31.2. South America Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Short-Acting Insulin Market

32.1. Brazil Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Short-Acting Insulin Market

33.1. Middle East Short-Acting Insulin Market Overview

33.2. Middle East Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Short-Acting Insulin Market

34.1. Africa Short-Acting Insulin Market Overview

34.2. Africa Short-Acting Insulin Market, Segmentation By Formulation, Segmentation By Dosage Form, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Short-Acting Insulin Market Regulatory and Investment Landscape

36. Short-Acting Insulin Market Competitive Landscape And Company Profiles

36.1. Short-Acting Insulin Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Short-Acting Insulin Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Short-Acting Insulin Market Company Profiles

36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Biocon Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Lupin Limited Overview, Products and Services, Strategy and Financial Analysis

37. Short-Acting Insulin Market Other Major And Innovative Companies

Wockhardt Ltd., Julphar (Gulf Pharmaceutical Industries), Geropharm LLC, Bioton S.A., Gan & Lee Pharmaceuticals Co. Ltd., Lannett Company Inc., MannKind Corporation, ADOCIA S.A.S., Baxter International Inc., Tonghua Dongbao Pharmaceutical Co. Ltd., United Laboratories International Holdings Ltd., Bharat Biotech International Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd., Dongbao Enterprise Group Co. Ltd., Aspen Pharmacare Holdings Limited

38. Global Short-Acting Insulin Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Short-Acting Insulin Market

40. Short-Acting Insulin Market High Potential Countries, Segments and Strategies

40.1 Short-Acting Insulin Market In 2030 - Countries Offering Most New Opportunities

40.2 Short-Acting Insulin Market In 2030 - Segments Offering Most New Opportunities

40.3 Short-Acting Insulin Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Short-Acting Insulin Market, Overview Of Key Products - Product Examples

Table 2: Global Short-Acting Insulin Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Short-Acting Insulin Market, Supply Chain Analysis

Table 4: Global Short-Acting Insulin Market, Major Raw Material Providers

Table 5: Global Short-Acting Insulin Market, Major Resource Providers

Table 6: Global Short-Acting Insulin Market, Major Manufacturers (Suppliers)

Table 7: Global Short-Acting Insulin Market, Major Distributors And Channel Partners

Table 8: Global Short-Acting Insulin Market, Key Technologies & Future Trends

Table 9: Global Short-Acting Insulin Market, Major Trends

Table 10: Global Short-Acting Insulin Market, Major End Users

Table 11: Global Short-Acting Insulin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Short-Acting Insulin Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Short-Acting Insulin Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Short-Acting Insulin Market - TAM, US$ Billion, 2025

Table 15: Global Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Short-Acting Insulin Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Short-Acting Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Short-Acting Insulin Market, Sub-Segmentation Of Regular Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Short-Acting Insulin Market, Sub-Segmentation Of Rapid-Acting Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Short-Acting Insulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Short-Acting Insulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Short-Acting Insulin Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Short-Acting Insulin Market - Company Scoring Matrix

Table 98: Sanofi S.A. Financial Performance

Table 99: Eli Lilly and Company Financial Performance

Table 100: Novo Nordisk A/S Financial Performance

Table 101: Biocon Limited Financial Performance

Table 102: Lupin Limited Financial Performance

Table 103: Global Short-Acting Insulin Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Short-Acting Insulin Market, Competitive Dashboard

Table 105: Global Short-Acting Insulin Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Short-Acting Insulin Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030

Table 107: Global, Short-Acting Insulin Market Size Gain ($ Billion), Segmentation By Dosage Form, 2025 – 2030

Table 108: Global, Short-Acting Insulin Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Short-Acting Insulin Market, Overview Of Key Products - Product Examples

Figure 2: Global Short-Acting Insulin Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Short-Acting Insulin Market, Supply Chain Analysis

Figure 4: Global Short-Acting Insulin Market, Major Raw Material Providers

Figure 5: Global Short-Acting Insulin Market, Major Resource Providers

Figure 6: Global Short-Acting Insulin Market, Major Manufacturers (Suppliers)

Figure 7: Global Short-Acting Insulin Market, Major Distributors And Channel Partners

Figure 8: Global Short-Acting Insulin Market, Key Technologies & Future Trends

Figure 9: Global Short-Acting Insulin Market, Major Trends

Figure 10: Global Short-Acting Insulin Market, Major End Users

Figure 11: Global Short-Acting Insulin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Short-Acting Insulin Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Short-Acting Insulin Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Short-Acting Insulin Market - TAM, US$ Billion, 2025

Figure 15: Global Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Short-Acting Insulin Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Short-Acting Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Short-Acting Insulin Market, Sub-Segmentation Of Regular Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Short-Acting Insulin Market, Sub-Segmentation Of Rapid-Acting Insulin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Short-Acting Insulin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Short-Acting Insulin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Short-Acting Insulin Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Short-Acting Insulin Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Short-Acting Insulin Market - Company Scoring Matrix

Figure 98: Sanofi S.A. Financial Performance

Figure 99: Eli Lilly and Company Financial Performance

Figure 100: Novo Nordisk A/S Financial Performance

Figure 101: Biocon Limited Financial Performance

Figure 102: Lupin Limited Financial Performance

Figure 103: Global Short-Acting Insulin Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Short-Acting Insulin Market, Competitive Dashboard

Figure 105: Global Short-Acting Insulin Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Short-Acting Insulin Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030

Figure 107: Global, Short-Acting Insulin Market Size Gain ($ Billion), Segmentation By Dosage Form, 2025 – 2030

Figure 108: Global, Short-Acting Insulin Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Instant Tea Premix Market Report 2026 - Global Outlook – By Product type (Cardamom Tea Premix, Ginger Tea Premix, Masala Tea Premix, Lemon Tea Premix, Plain Tea Premix, Lemon Grass Tea Premix), By Nature (Organic Tea Pre...

Technical Insulation Market Report 2026 - Global Outlook – By Product (Flexible Foam, Rigid Foam, Man-made Mineral Fiber ), By Application (Heating & Plumbing, HVAC, Refrigeration, Industrial Processes), By End User (Ind...

OEM Insulation Market Report 2026 - Global Outlook – By Insulation Type (Blankets, Rolls And Batts, Other Insulation Types ), By Material Type (Mineral Wool, Polyurethane Foam (PUF), Flexible Elastomeric Foam (FEF), Othe...

Non-injectable Insulin Market Report 2026 - Global Outlook – By Insulin Type (Oral Insulin, Inhaled Insulin, Nasal Insulin, Buccal Or Sublingual Insulin, Transdermal Insulin), By Product (Pills, Sprays, Other Products), ...

Insulin Aspart Market Report 2026 - Global Outlook – By Insulin Type (Human Insulin, Analog Insulin), By Product Type (Vials, Pre-Filled Pens, Cartridges), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Di...

Insulin Delivery Devices Market Report 2026 - Global Outlook – By Type (Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens), By Disease Indication (Type 1, Type 2), By Di...

Non-Insulin Therapies For Diabetes Market Report 2026 - Global Outlook – By Type (Biguanides, Sulfonylureas, Thiazolidinediones (TZDs), DPP 4 Inhibitors, GLP 1 Analogs Or Agonists, SGLT2 Inhibitors), By Route Of Administ...

Frequently Asked Questions

How big is the Short-Acting Insulin Market?

The Short-Acting Insulin market was valued at $11.54 billion in 2025, increased to $12.14 billion in 2026, and is projected to reach $14.87 billion by 2030.

What is the Short-Acting Insulin market growth?

The global Short-Acting Insulin market is expected to grow at a CAGR of 5.2% from 2026 to 2035 to reach $14.87 billion by 2035.

Who are the key players in Short-Acting Insulin market?

Some Key Players in the Short-Acting Insulin market Include, Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, Biocon Limited, Lupin Limited, Wockhardt Ltd., Julphar (Gulf Pharmaceutical Industries), Geropharm LLC, Bioton S.A., Gan & Lee Pharmaceuticals Co. Ltd., Lannett Company Inc., MannKind Corporation, ADOCIA S.A.S., Baxter International Inc., Tonghua Dongbao Pharmaceutical Co. Ltd., United Laboratories International Holdings Ltd., Bharat Biotech International Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd., Dongbao Enterprise Group Co. Ltd., Aspen Pharmacare Holdings Limited .

What is the anticipated growth trend for the Short-Acting Insulin market?

Major trend in this market includes: Advancing Interchangeable Rapid-Acting Insulin For Flexible Diabetes Management . For further insights on this market. request a sample here

Which region has the most growth potential in the Short-Acting Insulin market?

North America was the largest region in the short-acting insulin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short-acting insulin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.